Organ meat consumption and risk of nonalcoholic fatty liver disease: the TCLSIH study – PubMed
Organ meats and higher risk of NAFLD
Related Articles
Medicare fee-for-service
Grasp the changing landscape of Medicare with important information. Includes physician fee schedules, medicare administrative contractor, and E/M resources.
Rip-off America? From car rentals to coffee, inflation is rampant
Supply problems, fuel prices and corporate greed all contributed to pushing costs higher for families and tourists — and the effect of tariffs is still…
Review Highlights Benefits, Drawbacks of Dual Biologic Therapy in Dermatology
This systematic review evaluated current research on dual biologic treatments in patients living with inflammatory skin conditions.
Review Highlights Benefits, Drawbacks of Dual Biologic Therapy in Dermatology
This systematic review evaluated current research on dual biologic treatments in patients living with inflammatory skin conditions.
Timing of ESR1 Mutation Testing Is Critical to Overcome Adaptive Endocrine Resistance in HR+ Breast Cancer
Kevin Kalinsky, MD, MS, FASCO, discusses how findings from SERENA-6 reinforce the importance of timely ESR1 testing in HR-positive breast cancer.
Inside payers’ latest plans to streamline prior authorization
Cautious optimism is the watchword for physicians tired of seeing their patients’ care delayed. The AMA is fighting to fix prior authorization.
Can Automation Increase Investment in Gene Therapies?
The potential of gene therapies will only be realized if the manufacturing challenges can be resolved, and that’s a tricky task.
Regulatory and Clinical Outcomes of Nononcology Accelerated Approvals
This study uses US Food and Drug Administration (FDA) data to characterize pivotal and confirmatory trials supporting agency decision-making in the context of the FDA…
Microdosing: how ‘off-label’ use of weight loss jabs is spreading from US to UK
Private clinics offer reduced doses of GLP-1 drugs such as Mounjaro to clients outside usual market, but some people are wary
Microbiota-driven antitumour immunity mediated by dendritic cell migration
Nature – A newly identified bacterial strain (YB328) isolated from the faeces of patients who responded to immune checkpoint blockade therapies can promote antitumour immunity…
